Nasdaq · Biotech stocks database

AGMB — AgomAb Therapeutics NV

AGMB (AgomAb Therapeutics NV) stock: $11.85, $583.3M market cap, $101.5M cash, $481.8M EV, $1.08B fully diluted market cap. Data from Fully Diluted's biotech stocks database.

Share price

$11.85

Market cap

$583.3M

Cash

$101.5M

Enterprise value

$481.8M

Balance sheet

Cash	$101.5M
Debt	$0.0M
Net cash	$101.5M
Enterprise value	$481.8M
Basic shares	49.2M shares
Fully diluted shares	91.1M shares
Fully diluted market cap	$1,080.1M
Cash per share	$2.06

Cash figures as of 2025-12-31. Database snapshot: 2026-09-22.

Price history

Loading AGMB daily closes…

Loading price history…

Institutional holders

Fund	Shares	Q/Q change	% of portfolio	Filing
OrbiMed Advisors	192,740	+192,740	0.05%	2026-08-14

Institutional holder positions from 13F filings. Q/Q change is vs the prior quarter's filing; % of portfolio is the fund's own reported portfolio weight.

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 714 stocks.

Subscribe to Compounding Ego